Insights on Pharmaceuticals & Medical Products

Article

An inflection point for biosimilars

– With rising US adoption, biosimilars are gathering even more momentum. Successful companies will innovate their commercial models, rethink their portfolio management, and accelerate their R&D.
Article - McKinsey Global Institute

How keeping health a priority is a prescription for European prosperity

– As Europe emerges from the pandemic, investing in health can not only save lives and build greater resilience but underpin economic... growth and prosperity.
Article

Leveraging digital and analytics in biopharma operations: Six principles

– Digital and analytics is a powerful tool for transforming operational performance. To maximize its benefits, biopharma companies... can follow six principles.

Article

Fast-forward: Will the speed of COVID-19 vaccine development reset industry norms?

– A review of the funding, operational, technological, and regulatory factors that allowed for fast development of COVID-19 vaccines... shows which will remain relevant for future efforts—and which won’t.
Article

Omnichannel engagement in medtech: The time is now

– Leading medtech companies are shifting to omnichannel models to build personalized engagement and stronger relationships with... healthcare professionals, which will ultimately translate into better care for patients.
Article

The essentials of healthcare innovation

– The pandemic has raised the importance of healthcare organizations actively choosing, evolving, accelerating, and extending their... innovation efforts, a new survey reveals.
Podcast - McKinsey Global Institute

Forward Thinking on the Bio Revolution with Jason Kelly and Dr. Michelle McMurry-Heath

– The leaders of Ginkgo Bioworks and the BIO organization discuss the future of biological technologies, from developing vaccines... faster to changing how we produce food.
Article

How the medtech industry can capture value from digital health

– Medtech companies could play a major role in the digital transformation of healthcare that is under way, but they will have to... make some big changes to the way they operate—and fast.
Executive Briefing

COVID-19: Implications for business

– Our latest perspectives on the coronavirus outbreak, the twin threats to lives and livelihoods, and how organizations can prepare... for the next normal.

Special collection

Future of pharma operations

Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations. Contact us to learn more.

Coronavirus vaccines progress: What’s next?

The rapid development of the COVID-19 vaccines is having a profound effect on the world. This collection takes a closer look at the development, rollout and future of vaccines.

McKinsey insights on cell and gene therapy

Continuing advances in cell and gene therapy (CGT) are transforming how we treat and potentially cure certain diseases. This collection of articles provides an in-depth look at the opportunities and challenges ahead and the implications for stakeholders in this fast-evolving field. Contact us to learn more.

The rise of health technology

Health technology continues to push the boundaries of how healthcare is delivered and has the power to create breakthroughs in our understanding of disease. This collection of articles and interviews explores the evolving role of health technology in the life-sciences sector and implications for key stakeholders. Contact us to learn more about our work in this field.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

More insights

Article

No place like home? Stepping up the decentralization of clinical trials

– The COVID-19 pandemic has catalyzed the adoption of decentralized clinical trials while highlighting the critical benefits of... virtual trials and improving the patient and physician experience.
Commentary

India’s tragedy reverberates around the world

– The COVID-19 crisis in India offers a stark reminder that what’s happening there could happen anywhere.
Article

Not the last pandemic: Investing now to reimagine public-health systems

– The COVID-19 crisis reminds us how underprepared the world was to detect and respond to emerging infectious diseases. Smart investments... of as little as $5 per person per year globally can help ensure far better preparation for future pandemics.
Article

The road to digital transformation: Roles and requirements for organizational success

– A panel of pharma digital leaders discusses pathways for technology and data scale-up—and the skills, mindsets, and C-suite influences... needed to drive true digital transformation.
Article

What’s ahead for biotech: Another wave or low tide?

– Even in tough times, investor expectations and deal making in biotech are surging. Can the sector maintain its strong growth?
Article

Fulfilling the promise of advanced analytics in oncology

– Advanced analytics will transform cancer care, but companies have been slow to adopt it. Progress requires a strategy that not... only builds data and talent but also embraces experimentation.
Article

Africa needs vaccines. What would it take to make them here?

– For decades, private companies, investors, and public-health leaders have taken a pass on domestic vaccine manufacturing. But... a confluence of circumstances may be changing the calculation.
Article

Digitization, automation, and online testing: Embracing smart quality control

– The smart quality approach allows pharma companies to digitize, automate, and integrate their quality controls, making them faster,... more effective, and more efficient.
Article

Getting to work: Employers’ role in COVID-19 vaccination

– Employers can consider a set of actions that supports COVID-19-vaccine adoption among employees by building conviction and making... vaccination as convenient and “costless” as possible.
Article

Genomic sequencing: A vital tool in combatting the pandemic

– As variants of the COVID-19 virus emerge, genomic sequencing could help boost the public health response and provide the impetus... to create value for future crises.
Article

All in the mix: Why US COVID-19 cases rose and fell, and what comes next

– Some people get out and about more than others. That might be a key and overlooked factor in recent declines in US COVID-19 case... counts—and could have implications as society reopens.
Sorry, we couldn't find any results. Try removing some filters.

Connect with our Pharmaceuticals & Medical Products Practice